FENOFIBRATE

Product NDC: 51655-009
11-digit product format: 516550009
Labeler code: 51655
Product ID: 51655-009_46dda39a-93fb-1900-e063-6294a90a96f4
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: FENOFIBRATE
Dosage form: TABLET
Route: ORAL
Labeler: Northwind Health Company, LLC
Application: ANDA076509
Marketing category: ANDA
Marketing start: 2014-05-07
Substance: FENOFIBRATE
Active strength: 160 mg/1
Pharmacologic classes: Peroxisome Proliferator Receptor alpha Agonist [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 14 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	51655-009-52	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	51655-009-52	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	51655-009-52	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	51655-009-52	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	51655-009-52	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	51655-009-52	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	51655-009-52	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A076509-001	FENOFIBRATE	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26
A076509-002	FENOFIBRATE	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A076509-001	AB
A076509-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A076509-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076509-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076509-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076509-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A076509-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076509-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076509-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076509-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076509-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076509-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076509-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076509-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076509-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076509-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076509-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076509-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076509-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076509-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A076509-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076509-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076509-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076509-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076509-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076509-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076509-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076509-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A076509-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A076509-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A076509-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A076509-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A076509-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A076509-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A076509-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A076509-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A076509-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A076509-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A076509-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A076509-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A076509-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A076509-002	AB	1	`782e0a99824c…`

Additional Listing Data#

Finished product: Yes
Brand name base: FENOFIBRATE
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
FENOFIBRATE	160 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
U202363UOS	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
349287	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
4b4447a1-8136-4258-b2c8-c5f9c1bcec92	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
193bb7da-5c03-8f95-9048-23ef403846b0	Product name	3	20250616
fa35fb9a-7146-716b-13c8-bc1f60030232	Product name	9	20250114
cfc78bfa-7d55-47e5-aeb7-71cd79f5ca07	Product name	8	20231212
53d5b6b7-785a-4500-9460-263c7f8424b8	Product name	5	20210105
ed9d55d4-85bd-0ee7-5b4a-b705646a3a66	Product name	9	20200708
36a239c8-03fb-0083-81af-6c1afb195671	Product name	1	20140508
a0296d70-ca85-018c-84e8-cf3f630976b7	Product name	1	20140508
f2e3e9c8-a2f9-0cc3-a5a5-6dfd0279372a	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
51655-009-52	2023-02-17	C162847	48780-1	9d75b9d0-a8bb-f424-e053-dadaa90a57ce	These highlights do not include all the information needed to use FENOFIBRATE TABLETS safely and effectively. See full prescribing information for FENOFIBRATE TABLETS. FENOFIBRATE tablets, for oral use Initial U.S. Approval: 1993
51655-009-52	2020-01-31	C162847	48780-1	9d75b9d0-a8bb-f424-e053-dadaa90a57ce	These highlights do not include all the information needed to use FENOFIBRATE TABLETS safely and effectively. See full prescribing information for FENOFIBRATE TABLETS. FENOFIBRATE tablets, for oral use Initial U.S. Approval: 1993

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
51655-009-52	FENOFIBRATE	30 in 1 BOTTLE, DISPENSING	TABLET	30		5

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version	Uploaded
FENOFIBRATE	ACTIVE INGREDIENT	U202363UOS	FENOFIBRATE TABLET [NORTHWIND PHARMACEUTICALS]	1
FENOFIBRATE	ACTIVE MOIETY	U202363UOS	FENOFIBRATE TABLET [NORTHWIND PHARMACEUTICALS]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
51655-009	FENOFIBRATE TABLET [NORTHWIND PHARMACEUTICALS, LLC]	4	Current NDC, Legacy NDC, 1 package rows	20241215_4b4447a1-8136-4258-b2c8-c5f9c1bcec92.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 8 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
FENOFIBRATE	FENOFIBRATE	Amneal Pharmaceuticals LLC	65f5dcad-5073-4347-9ec9-e7f350b134c4	2026-06-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076509 application number: ANDA076509
FENOFIBRATE	FENOFIBRATE	Northwind Health Company, LLC	4b4447a1-8136-4258-b2c8-c5f9c1bcec92	2025-12-26	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076509 application number: ANDA076509 ndc (product): 51655-009
FENOFIBRATE	FENOFIBRATE	AvPAK	d4e1d692-3c03-7406-ee06-7a6fb39ed3e7	2025-11-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076509 application number: ANDA076509
FENOFIBRATE	FENOFIBRATE	REMEDYREPACK INC.	882ee82a-3c56-4173-af42-68c3aadc8aa7	2025-10-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076509 application number: ANDA076509
FENOFIBRATE	FENOFIBRATE	PD-Rx Pharmaceuticals, Inc.	35ba17d9-0dd7-4f15-8f74-be5fd15f1917	2025-04-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076509 application number: ANDA076509
FENOFIBRATE	FENOFIBRATE	A-S Medication Solutions	3f2b3a16-7735-487e-9a2c-e078a18df1bc	2024-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076509 application number: ANDA076509
FENOFIBRATE	FENOFIBRATE	A-S Medication Solutions	f937a176-3d3e-4dc6-a7d4-c1a4749c7a7f	2023-12-27	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076509 application number: ANDA076509
FENOFIBRATE	FENOFIBRATE	Amneal Pharmaceuticals of New York LLC	fa08cf6a-d306-4979-9b23-ac7febf4fd12	2021-04-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076509 application number: ANDA076509

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
U202363UOS	FENOFIBRATE	49562-28-9	FENOFIBRATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
349287	fenofibrate 160 MG Oral Tablet	PSN	4b4447a1-8136-4258-b2c8-c5f9c1bcec92	5
349287	fenofibrate 160 MG Oral Tablet	SCD	4b4447a1-8136-4258-b2c8-c5f9c1bcec92	5

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Sample	Exclude flag	Status
51655-009-52	51655000952	30 TABLET in 1 BOTTLE, DISPENSING (51655-009-52)	30 tablet	2014-05-07	No	No	Current